Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Oncology
Published in: International Journal of Clinical Oncology 3/2005

01-06-2005 | CASE REPORT

Bone metastasis of intracranial meningeal hemangiopericytoma

Authors: Manabu Hoshi, Nobuhito Araki, Norifumi Naka, Masahiko Koizumi, Nobuyuki Hashimoto, Masayuki Onishi, Kenjiro Sugiyasu, Nobuhito Kimura, Shigeki Mori, Kinji Nishiyama, Hideki Yoshikawa

Published in: International Journal of Clinical Oncology | Issue 3/2005

Login to get access
Metadata
Title
Bone metastasis of intracranial meningeal hemangiopericytoma
Authors
Manabu Hoshi
Nobuhito Araki
Norifumi Naka
Masahiko Koizumi
Nobuyuki Hashimoto
Masayuki Onishi
Kenjiro Sugiyasu
Nobuhito Kimura
Shigeki Mori
Kinji Nishiyama
Hideki Yoshikawa
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
International Journal of Clinical Oncology / Issue 3/2005
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-005-0476-y

Other articles of this Issue 3/2005

International Journal of Clinical Oncology 3/2005 Go to the issue

ORIGINAL ARTICLE

Incidence of postoperative ileus after paraaortic lymph node dissection in patients with malignant gynecologic tumors

CASE REPORT

Symptomatic metastases to the pituitary infundibulum resulting from primary breast cancer

FROM THE ASCO-JSCO JOINT SYMPOSIUM

Clinical trials of surgical treatment of malignant diseases

ORIGINAL ARTICLE

Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer

ORIGINAL ARTICLE

Treatment of androgen-independent, hormone-refractory prostate cancer with docetaxel in Japanese patients

CASE REPORT

Laryngeal squamous cell carcinoma with ectopic production of granulocyte colony-stimulating factor and parathyroid hormone-related protein
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits